A carregar...

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis

An accurate and early diagnosis of Alzheimer’s disease (AD) is important to select optimal patient care and is critical in current clinical trials targeting core AD neuropathological features. The past decades, much progress has been made in the development and validation of cerebrospinal fluid (CSF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Alzheimers Dis
Main Authors: Bjerke, Maria, Engelborghs, Sebastiaan
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870045/
https://ncbi.nlm.nih.gov/pubmed/29562530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170680
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!